drug company funding for drug trials is leading to biased findings and inappropriate prescribing

There's growing concern that drug company funding for drug trials is leading to biased findings and inappropriate prescribing.

In May we told you how physicians select one drug over another based on the way study results are presented.

Now the AMA just launched a campaign to draw attention to "publication bias"...and to get gov't help to curb these practices.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote